We herein report a faster and less cumbersome synthesis of the biologically attractive, α-galactosyl ceramide (α-GalCer), known as KRN7000, and its analogues. More importantly, the use of a silicon tethered intramolecular glycosylation reaction gave easy access to the diglycosyl ceramide Gal(α1→2)GalCer, which has been shown to require uptake and processing to the biologically active α-GalCer derivative
The glycolipid α-galactosyl ceramide, α-GalCer, has been shown to stimulate the proliferation of mur...
AbstractSeveral l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and r...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
AbstractWe herein report a faster and less cumbersome synthesis of the biologically attractive, α-ga...
We herein report a faster and less cumbersome synthesis of the biologically attractive, alpha-galact...
A concise route to the 6-azido-6-deoxy-α-galactosyl-phytosphingosine derivative 9 is reported. Ortho...
Several L-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoi...
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulatio...
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulatio...
AbstractStimulation of iNKT cells by α-galactosyl ceramide (α-GalCer), also known as KRN7000, and it...
Abstractα-Glucosyl ceramides 4 and 5 have been synthesised and evaluated for their ability to stimul...
AbstractA library of dimeric CD1d ligands, containing two α-galactosyl ceramide (α-GalCer) units lin...
a-Glucosyl ceramides 4 and 5 have been synthesised and evaluated for their ability to stimulate the ...
A synthesis strategy for the swift generation of 4"-modified alpha-galactosylceramide (alpha-GalCer)...
A new practical synthesis of alpha-GalCer and of its analogues is presented, opening the chance to e...
The glycolipid α-galactosyl ceramide, α-GalCer, has been shown to stimulate the proliferation of mur...
AbstractSeveral l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and r...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...
AbstractWe herein report a faster and less cumbersome synthesis of the biologically attractive, α-ga...
We herein report a faster and less cumbersome synthesis of the biologically attractive, alpha-galact...
A concise route to the 6-azido-6-deoxy-α-galactosyl-phytosphingosine derivative 9 is reported. Ortho...
Several L-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoi...
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulatio...
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulatio...
AbstractStimulation of iNKT cells by α-galactosyl ceramide (α-GalCer), also known as KRN7000, and it...
Abstractα-Glucosyl ceramides 4 and 5 have been synthesised and evaluated for their ability to stimul...
AbstractA library of dimeric CD1d ligands, containing two α-galactosyl ceramide (α-GalCer) units lin...
a-Glucosyl ceramides 4 and 5 have been synthesised and evaluated for their ability to stimulate the ...
A synthesis strategy for the swift generation of 4"-modified alpha-galactosylceramide (alpha-GalCer)...
A new practical synthesis of alpha-GalCer and of its analogues is presented, opening the chance to e...
The glycolipid α-galactosyl ceramide, α-GalCer, has been shown to stimulate the proliferation of mur...
AbstractSeveral l-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and r...
α-Galactosylceramide (KRN7000) was developed by Kirin Brewery Co., Ltd. in Japan. It exhibits potent...